跳到正文
原文
The Dark Report 实验室管理· Scott Wallask·· 2026-09-17AI 评分27

质谱技术演进瞄准临床实验室:灵敏度与易用性提升,成本与报销仍是障碍

Mass Spectrometry Evolves for Clinical Laboratories

AI 导读

质谱技术因其灵敏度和易用性提升,或可面向更广泛的临床实验室用户。但系统购置费用高昂与报销标准持平的现状,可能令成本敏感型机构顾虑。临床实验室决策者需在采用时权衡利弊。

正文

CEO Summary: Mass spectrometry may be ready for a wider audience within clinical laboratories, as the technology’s sensitivity and ease of use provide prime selling points for adoption. However, the expense of the systems, and flat reimbursement rates, may concern cost-sensitive organizations. Clinical lab decision-makers will need to weigh the pros and cons as they […]

来源:The Dark Report 实验室管理 · darkintelligencegroup.com